Experiences and perceptions of patients with psoriatic arthritis participating in a trial of faecal microbiota

Maja Skov Kragsnaes1, Shaun Theodor Sødergren2,3, Jens Kjeldsen4

  • 1Department of Rheumatology, Odense University Hospital, Odense, Denmark d063631@dadlnet.dk.

BMJ Open
|May 19, 2021
PubMed
Abstract

Insights

Patients undergoing faecal microbiota transplantation (FMT) for psoriatic arthritis found the treatment safe and acceptable. Trial participation positively impacted their understanding of the disease and daily life, fostering hope for future microbiota-targeted therapies in rheumatic diseases.

Area of Science:

  • Rheumatology
  • Gastroenterology
  • Microbiology

Background:

  • Faecal microbiota transplantation (FMT) is being investigated as a novel treatment for rheumatic diseases.
  • Patient experiences with FMT in rheumatological settings are not well understood.
  • Understanding patient perspectives is crucial for evaluating FMT's potential in rheumatology.

Purpose of the Study:

  • To explore patient experiences with FMT in a clinical trial for psoriatic arthritis.
  • To identify potential effects of trial participation on patients' lives.
  • To gauge patient perspectives on future FMT trials for rheumatic conditions.

Main Methods:

  • Qualitative study nested within a double-blind, randomized, placebo-controlled trial.
  • Semistructured telephone interviews conducted with 10 psoriatic arthritis patients post-trial.
  • Thematic analysis of interview data focusing on trial conduct and life changes.

Main Results:

  • Trial participation enhanced patients' understanding of psoriatic arthritis and improved their daily lives.
  • Patients reported renewed hope and a feeling of enhanced care.
  • Faecal microbiota transplantation was perceived as tolerable and safe.

Conclusions:

  • Patients with psoriatic arthritis found FMT acceptable and safe, supporting further research.
  • Trial participation itself yielded positive psychological and practical benefits for patients.
  • Consideration of clinical versus research settings is important for interpreting FMT trial outcomes.

Related Concept Videos

Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
249
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
475
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
73.5K